Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$942

Avg closing price
Price range

3 David Einhorn Talis Biomedical Trades

David Einhorn started to build up the position in Talis Biomedical in Q4 2021 and continued to invest until Q1 2022. Since then they sold 149 Thousand shares. The investor sold all their shares in Q3 2023 and doesn't own any shares in Talis Biomedical anymore.

Avg closing price
Price range
Sold -149 Thousand shares Q3 2023
Avg closing price $10.15
Price range $5.52 - $112.07
Increased shares by 42.5% (+44.4 Thousand shares) Q1 2022
Avg closing price $519.17
Price range $292.50 - $942.75
New holding (+105 Thousand shares) Q4 2021
Avg closing price $1,122.19
Price range $857.25 - $1,388.25

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!